Drugs / Glyceroltrinitrat
Glyceroltrinitrat
English name glyceroltrinitrate
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT05711199 | Mar 2023 → Jun 2025 | — | University Hospital, Basel, Switzerland | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Glyceroltrinitrat | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05711199 ↗ |
| Known as | glyceroltrinitrate | “The aim of this study is to evaluate the efficacy of glyceroltrinitrate (Nitroderm® TTS) to activate and expand human BAT as compared to mild cold exposure.” NCT05711199 ↗ |
| Known as | Nitroderm TTS | “The aim of this study is to evaluate the efficacy of glyceroltrinitrate (Nitroderm® TTS) to activate and expand human BAT as compared to mild cold exposure.” NCT05711199 ↗ |